Integral Health Asset Management is an investment fund managing more than $1.02 trillion ran by John Virginia. There are currently 76 companies in Mr. Virginia’s portfolio. The largest investments include Tenet Healthcare and Boston Scientific, together worth $85.8 billion.
As of 7th August 2024, Integral Health Asset Management’s top holding is 425,000 shares of Tenet Healthcare currently worth over $44.7 billion and making up 4.4% of the portfolio value.
Relative to the number of outstanding shares of Tenet Healthcare, Integral Health Asset Management owns more than approximately 0.1% of the company.
In addition, the fund holds 600,000 shares of Boston Scientific worth $41.1 billion, whose value grew 15.1% in the past six months.
The third-largest holding is Viking Therapeutics Inc worth $36.9 billion and the next is Insmed Inc worth $35.3 billion, with 1,300,000 shares owned.
Currently, Integral Health Asset Management's portfolio is worth at least $1.02 trillion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Integral Health Asset Management office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, John Virginia serves as the Chief Compliance Officer at Integral Health Asset Management.
In the most recent 13F filing, Integral Health Asset Management revealed that it had opened a new position in
Insmed Inc and bought 1,300,000 shares worth $35.3 billion.
This means they effectively own approximately 0.1% of the company.
Insmed Inc makes up
4.9%
of the fund's Health Care sector allocation and has grown its share price by 242.5% in the past year.
The investment fund also strengthened its position in Tenet Healthcare by buying
193,000 additional shares.
This makes their stake in Tenet Healthcare total 425,000 shares worth $44.7 billion.
Tenet Healthcare soared 106.9% in the past year.
On the other hand, there are companies that Integral Health Asset Management is getting rid of from its portfolio.
Integral Health Asset Management closed its position in Zimmer Biomet Inc on 14th August 2024.
It sold the previously owned 300,000 shares for $43.7 billion.
John Virginia also disclosed a decreased stake in Viking Therapeutics Inc by 0.4%.
This leaves the value of the investment at $36.9 billion and 450,000 shares.
The two most similar investment funds to Integral Health Asset Management are Sir Capital Management, L.P. and Paradigm Operations L.P.. They manage $1.01 trillion and $1 trillion respectively.
Integral Health Asset Management’s portfolio is diversified across 5 sectors.
Currently, their heaviest sector is Health Care — making up 70.3% of
the total portfolio value.
The fund focuses on investments in the United States as
63.2% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
24% of the total holdings value.
On the other hand, small-cap stocks make up only 1.3% of the portfolio.
The average market cap of the portfolio companies is close to $27.7 billion.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Tenet Healthcare Corp. |
83.19%
425,000
|
$44,671,750,000 | 4.39% |
| Zimmer Biomet Holdings Inc |
Closed
300,000
|
$43,680,000,000 | |
| Boston Scientific Corp. |
28.76%
600,000
|
$41,094,000,000 | 4.03% |
| Viking Therapeutics Inc |
38.36%
450,000
|
$36,900,000,000 | 3.62% |
| Insmed Inc |
Opened
1,300,000
|
$35,269,000,000 | 3.46% |
| Cytokinetics Inc |
30.77%
450,000
|
$31,549,500,000 | 3.10% |
| Merck & Co Inc |
Opened
235,000
|
$31,008,250,000 | 3.04% |
| Mckesson Corporation |
Closed
72,000
|
$30,766,320,000 | |
| Encompass Health Corp |
59.09%
350,000
|
$28,903,000,000 | 2.84% |
| Walgreens Boots Alliance Inc |
Opened
1,300,000
|
$28,197,000,000 | 2.77% |
| Elevance Health Inc |
66.67%
50,000
|
$25,927,000,000 | 2.55% |
| Abbvie Inc |
35.00%
135,000
|
$24,583,500,000 | 2.41% |
| Universal Hlth Svcs Inc |
Opened
125,000
|
$22,807,500,000 | 2.24% |
| Novartis AG |
118.45%
225,000
|
$21,764,250,000 | 2.14% |
| Tarsus Pharmaceuticals, Inc. |
Opened
590,000
|
$21,446,500,000 | 2.11% |
| Longboard Pharmaceuticals In |
63.04%
975,000
|
$21,060,000,000 | 2.07% |
| Humana Inc. |
Opened
60,000
|
$20,803,200,000 | 2.04% |
| Neurocrine Biosciences, Inc. |
Opened
150,000
|
$20,688,000,000 | 2.03% |
| Bruker Corp |
Opened
220,000
|
$20,666,800,000 | 2.03% |
| Intuitive Surgical Inc |
38.89%
50,000
|
$19,954,500,000 | 1.96% |
| Cooper Cos Inc |
Closed
52,000
|
$19,938,360,000 | |
| Blueprint Medicines Corp |
Opened
210,000
|
$19,920,600,000 | 1.96% |
| Arcellx Inc |
Opened
255,000
|
$17,735,250,000 | 1.74% |
| Charles Riv Labs Intl Inc |
Opened
65,000
|
$17,611,750,000 | 1.73% |
| Regeneron Pharmaceuticals, Inc. |
Opened
17,000
|
$16,362,330,000 | 1.61% |
| Regenxbio Inc |
Opened
760,000
|
$16,013,200,000 | 1.57% |
| Penumbra Inc |
133.33%
70,000
|
$15,622,600,000 | 1.53% |
| Argenx Se |
Closed
40,000
|
$15,589,200,000 | |
| Vera Therapeutics Inc |
Opened
360,000
|
$15,523,200,000 | 1.52% |
| Crinetics Pharmaceuticals In |
Opened
325,000
|
$15,213,250,000 | 1.49% |
| Icon Plc |
Opened
45,000
|
$15,117,750,000 | 1.48% |
| CRISPR Therapeutics AG |
120.00%
220,000
|
$14,995,200,000 | 1.47% |
| Cigna Group (The) |
77.78%
40,000
|
$14,527,600,000 | 1.43% |
| Krystal Biotech Inc |
29.03%
80,000
|
$14,234,400,000 | 1.40% |
| Hologic, Inc. |
Closed
175,000
|
$14,169,750,000 | |
| Dexcom Inc |
Opened
100,000
|
$13,870,000,000 | 1.36% |
| Revolution Medicines Inc |
17.98%
420,000
|
$13,536,600,000 | 1.33% |
| Centene Corp. |
Closed
200,000
|
$13,490,000,000 | |
| Schrodinger, Inc. |
Closed
265,000
|
$13,228,800,000 | |
| Shockwave Med Inc |
Opened
40,000
|
$13,025,200,000 | 1.28% |
| Avantor, Inc. |
Opened
500,000
|
$12,785,000,000 | 1.26% |
| Zentalis Pharmaceuticals, Llc |
Closed
450,000
|
$12,694,500,000 | |
| GSK Plc |
Closed
350,000
|
$12,474,000,000 | |
| Reata Pharmaceuticals Inc |
Closed
120,000
|
$12,235,200,000 | |
| Cencora Inc. |
92.31%
50,000
|
$12,149,500,000 | 1.19% |
| HCA Healthcare Inc |
Closed
40,000
|
$12,139,200,000 | |
| Danaher Corp. |
Closed
50,000
|
$12,000,000,000 | |
| Johnson & Johnson |
Closed
72,000
|
$11,917,440,000 | |
| Tenaya Therapeutics Inc |
Opened
2,250,000
|
$11,767,500,000 | 1.16% |
| Ventyx Biosciences Inc |
Closed
350,000
|
$11,480,000,000 | |
| Surgery Partners Inc |
Closed
250,000
|
$11,247,500,000 | |
| Cooper Cos Inc |
Opened
110,000
|
$11,160,600,000 | 1.10% |
| Moonlake Immunotherapeutics |
26.67%
220,000
|
$11,050,600,000 | 1.08% |
| Replimune Group Inc |
Closed
445,000
|
$10,332,900,000 | |
| Sana Biotechnology Inc |
Opened
980,000
|
$9,800,000,000 | 0.96% |
| Inari Med Inc |
29.03%
200,000
|
$9,596,000,000 | 0.94% |
| Eli Lilly & Co |
60.00%
12,000
|
$9,335,520,000 | 0.92% |
| Repligen Corp. |
Opened
50,000
|
$9,196,000,000 | 0.90% |
| Alpine Immune Sciences Inc |
Opened
230,000
|
$9,117,200,000 | 0.89% |
| Elanco Animal Health Inc |
175.00%
550,000
|
$8,954,000,000 | 0.88% |
| Apellis Pharmaceuticals Inc |
108.33%
150,000
|
$8,817,000,000 | 0.87% |
| Intra-Cellular Therapies Inc |
11.97%
125,000
|
$8,650,000,000 | 0.85% |
| Intellia Therapeutics Inc |
Closed
206,000
|
$8,400,680,000 | |
| Exact Sciences Corp. |
Closed
88,000
|
$8,263,200,000 | |
| Evolent Health Inc |
Opened
250,000
|
$8,197,500,000 | 0.80% |
| Tandem Diabetes Care Inc |
Opened
225,000
|
$7,967,250,000 | 0.78% |
| 4d Molecular Therapeutics In |
Opened
250,000
|
$7,965,000,000 | 0.78% |
| Teva Pharmaceutical Inds Ltd |
Closed
1,000,000
|
$7,530,000,000 | |
| Alnylam Pharmaceuticals Inc |
3.85%
50,000
|
$7,472,500,000 | 0.73% |
| Oscar Health, Inc. |
Opened
500,000
|
$7,435,000,000 | 0.73% |
| Merus N.V |
Opened
165,000
|
$7,429,950,000 | 0.73% |
| Macrogenics Inc |
Opened
500,000
|
$7,360,000,000 | 0.72% |
| Cabaletta Bio Inc |
Opened
425,000
|
$7,250,500,000 | 0.71% |
| Inspire Med Sys Inc |
67.96%
33,000
|
$7,088,070,000 | 0.70% |
| PTC Therapeutics Inc |
Closed
174,000
|
$7,076,580,000 | |
| Lifestance Health Group Inc |
Closed
773,000
|
$7,057,490,000 | |
| Medtronic Plc |
Closed
80,000
|
$7,048,000,000 | |
| Alkermes plc |
11.97%
250,000
|
$6,767,500,000 | 0.66% |
| Revance Therapeutics Inc |
Closed
250,000
|
$6,327,500,000 | |
| Roivant Sciences Ltd |
Opened
600,000
|
$6,324,000,000 | 0.62% |
| BeiGene Ltd |
Opened
40,000
|
$6,255,600,000 | 0.61% |
| TG Therapeutics Inc |
Closed
250,000
|
$6,210,000,000 | |
| SI-BONE Inc |
Closed
227,000
|
$6,124,460,000 | |
| Relay Therapeutics, Inc. |
3.57%
725,000
|
$6,017,500,000 | 0.59% |
| Scholar Rock Hldg Corp |
Opened
325,000
|
$5,772,000,000 | 0.57% |
| Revvity Inc. |
64.29%
50,000
|
$5,250,000,000 | 0.52% |
| Privia Health Group Inc |
Closed
200,000
|
$5,222,000,000 | |
| Envista Holdings Corp |
Closed
150,000
|
$5,076,000,000 | |
| Teladoc Health Inc |
Closed
200,000
|
$5,064,000,000 | |
| Align Technology, Inc. |
Opened
15,000
|
$4,918,800,000 | 0.48% |
| Amicus Therapeutics Inc |
Closed
387,000
|
$4,860,720,000 | |
| Natera Inc |
Opened
50,000
|
$4,573,000,000 | 0.45% |
| Laboratory Corp Amer Hldgs |
Opened
20,000
|
$4,369,200,000 | 0.43% |
| Agilent Technologies Inc. |
Opened
30,000
|
$4,365,300,000 | 0.43% |
| Cross Ctry Healthcare Inc |
Closed
155,000
|
$4,352,400,000 | |
| Biomarin Pharmaceutical Inc. |
Closed
50,000
|
$4,334,000,000 | |
| DENTSPLY Sirona Inc |
Closed
100,000
|
$4,002,000,000 | |
| BioNTech SE |
Closed
36,000
|
$3,885,480,000 | |
| Spyre Therapeutics Inc |
Opened
100,000
|
$3,793,000,000 | 0.37% |
| Sage Therapeutics Inc |
150.00%
200,000
|
$3,748,000,000 | 0.37% |
| Prothena Corp Plc |
Closed
52,000
|
$3,550,560,000 | |
| 89bio Inc |
Opened
300,000
|
$3,492,000,000 | 0.34% |
| Editas Medicine Inc |
Opened
450,000
|
$3,339,000,000 | 0.33% |
| Akero Therapeutics Inc |
Closed
70,000
|
$3,268,300,000 | |
| Autolus Therapeutics plc |
Opened
500,000
|
$3,190,000,000 | 0.31% |
| Mereo BioPharma Group plc |
Opened
950,000
|
$3,135,000,000 | 0.31% |
| Guardant Health Inc |
63.59%
150,000
|
$3,094,500,000 | 0.30% |
| Apogee Therapeutics Inc |
Opened
40,000
|
$2,658,000,000 | 0.26% |
| Keros Therapeutics, Inc. |
23.08%
40,000
|
$2,648,000,000 | 0.26% |
| Axsome Therapeutics Inc |
Opened
30,000
|
$2,394,000,000 | 0.24% |
| Supernus Pharmaceuticals Inc |
Closed
75,000
|
$2,254,500,000 | |
| Protagonist Therapeutics Inc |
Closed
75,000
|
$2,071,500,000 | |
| Allogene Therapeutics Inc |
Closed
412,000
|
$2,047,640,000 | |
| Terns Pharmaceuticals Inc |
Closed
180,000
|
$1,575,000,000 | |
| Fate Therapeutics Inc |
Opened
200,000
|
$1,468,000,000 | 0.14% |
| Dyne Therapeutics, Inc. |
Closed
62,000
|
$697,500,000 | |
| No transactions found | |||
| Showing first 500 out of 116 holdings | |||